XML 21 R10.htm IDEA: XBRL DOCUMENT v3.5.0.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2016
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies
Commitments and Contingencies
 
Operating Leases
 
The Company leases its headquarters and South San Francisco, California laboratory facilities under a non-cancelable lease agreement for approximately 59,000 square feet. The lease began in June 2015 and ends in March 2026 and contains extension of lease term and expansion options. The Company had deposits of $603,000 included in long-term assets as of June 30, 2016, restricted from withdrawal and held by a bank in the form of collateral for an irrevocable standby letter of credit held as security for the lease of the South San Francisco facility.
 
The Company also leases laboratory and office space in Austin, Texas. The lease expires on July 31, 2018. The Company provided a cash security deposit of $75,000, which is included in other assets in the Company’s condensed balance sheets as of June 30, 2016 and December 31, 2015.

Future minimum lease payments under non-cancelable operating leases as of June 30, 2016 are as follows (in thousands of dollars):
 
Year Ending December 31,
 
2016
$
1,047

2017
2,143

2018
2,102

2019
2,026

2020
2,082

Thereafter
11,956

Total minimum lease payments
$
21,356


 
The Company recognizes rent expense on a straight-line basis over the non-cancelable lease period. Facilities rent expense was $457,000 and $352,000 for the three months ended June 30, 2016 and 2015, respectively, and $1.1 million and $565,000 for the six months ended June 30, 2016 and 2015, respectively.
 
Supplies Purchase Commitments
 
The Company had non-cancelable purchase commitments with two suppliers to purchase a minimum quantity of supplies for approximately $1.1 million at June 30, 2016.

Debt Obligations
 
See Note 6, Debt.
 
Contingencies
 
From time to time, the Company may be involved in legal proceedings arising in the ordinary course of business. The Company believes there is no litigation pending that could have, individually or in the aggregate, a material adverse effect on the Company’s financial position, results of operations or cash flows.